A pilot randomized trial to evaluate the efficacy of oral and nasal povidone iodine in reducing the burden of severe acute respiratory syndrome coronavirus 2 RNA in patients with coronavirus disease 2019

Infect Control Hosp Epidemiol. 2023 Apr;44(4):679-681. doi: 10.1017/ice.2022.257. Epub 2022 Oct 21.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • COVID-19*
  • Humans
  • Pilot Projects
  • Povidone-Iodine*
  • RNA
  • SARS-CoV-2

Substances

  • Povidone-Iodine
  • RNA